Literature DB >> 24733327

New therapy for managing moderate to severe chronic obstructive pulmonary disease.

Andrew Chou, Anthony D D'Urzo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24733327      PMCID: PMC4046540     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  3 in total

1.  Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.

Authors:  Peter M A Calverley; Julie A Anderson; Bartolome Celli; Gary T Ferguson; Christine Jenkins; Paul W Jones; Julie C Yates; Jørgen Vestbo
Journal:  N Engl J Med       Date:  2007-02-22       Impact factor: 91.245

2.  Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2008 update - highlights for primary care.

Authors:  Denis E O'Donnell; Paul Hernandez; Alan Kaplan; Shawn Aaron; Jean Bourbeau; Darcy Marciniuk; Meyer Balter; Gordon Ford; Andre Gervais; Yves Lacasse; Francois Maltais; Jeremy Road; Graeme Rocker; Don Sin; Tasmin Sinuff; Nha Voduc
Journal:  Can Respir J       Date:  2008 Jan-Feb       Impact factor: 2.409

3.  A 4-year trial of tiotropium in chronic obstructive pulmonary disease.

Authors:  Donald P Tashkin; Bartolome Celli; Stephen Senn; Deborah Burkhart; Steven Kesten; Shailendra Menjoge; Marc Decramer
Journal:  N Engl J Med       Date:  2008-10-05       Impact factor: 91.245

  3 in total
  1 in total

1.  Lungs deposition and pharmacokinetic study of submicron budesonide particles in Wistar rats intended for immediate effect in asthma.

Authors:  Abdul Rauf; Aseem Bhatnagar; S S Sisodia; Roop K Khar; Farhan J Ahmad
Journal:  EXCLI J       Date:  2017-03-10       Impact factor: 4.068

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.